Kyverna (KYTX) Could Become the 1st $10B Autoimmune CAR T Company
Kyverna Therapeutics Inc. (NASDAQ:KYTX) is a clinical-stage biopharmaceutical company focused on transforming the treatment paradigm for autoimmune diseases…
Browsing Tag